Company news
908 Devices Inc. (NASDAQ:MASS) news
Every 908 Devices Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference
August 12, 2026
908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook
August 11, 2026
908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 29, 2026
908 Devices to Report Second Quarter 2026 Financial Results on August 11, 2026
July 28, 2026
908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 2, 2026
908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference
May 28, 2026
908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook
May 6, 2026
908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio
May 6, 2026
908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026
May 1, 2026
908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c...
April 21, 2026
Masivo Silver Extends and Completes First Hole at Cerro Colorado Project
April 8, 2026
908 Devices to Present at the Sidoti Small Cap Conference
March 16, 2026
908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook
March 3, 2026
908 Devices to Participate in Investor Conferences in March
February 24, 2026
908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
February 17, 2026
908 Devices Enhances MX908 Usability and Adds New Drug Targets
February 5, 2026
908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025
January 20, 2026
908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
November 10, 2025
908 Devices to Participate in Upcoming Investor Conferences
October 30, 2025
United States Coast Guard Purchases 908 Devices’ Handheld Mass Spec Devices for Chemical Threat Identification
October 28, 2025
908 Devices to Report Third Quarter 2025 Financial Results on November 10 2025
October 23, 2025
908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025
October 22, 2025
United States Marine Corps Purchases 908 Devices XplorIR Gas Identification Devices
October 17, 2025
United States Marine Corps Purchases 908 Devices’ XplorIR Gas Identification Devices
October 16, 2025
908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook
August 5, 2025
908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to ...
August 4, 2025
908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 29, 2025
908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025
July 22, 2025
908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances
July 8, 2025
Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500
June 25, 2025
908 Devices Appoints Christopher D. Brown to its Board of Directors
June 16, 2025
Metropolitan Washington Council of Governments Adds 908 Devices’ XplorIR to Its Hazardous Materials Response Toolkit
June 3, 2025
Romanian Customs Authority Adopts 908 Devices’ MX908 for Border Security Operations
May 28, 2025
908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference
May 22, 2025
908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
May 13, 2025
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection
April 30, 2025
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation
April 22, 2025
908 Devices Announces Preliminary First Quarter 2025 Financial Results
April 15, 2025
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device
March 11, 2025
908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results
March 4, 2025
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
March 4, 2025
908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
March 3, 2025
908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
January 14, 2025
908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
November 12, 2024
908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024
October 22, 2024
908 Devices to Participate in Craig-Hallum Bioprocessing Conference
September 6, 2024
908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook
August 6, 2024
908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference
July 30, 2024
908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024
July 23, 2024
908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board o...
June 25, 2024